Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Survival of people living with HIV who defaulted from tuberculosis treatment in a cohort, Recife, Brazil

Authors: R Cunha, M Maruza, UR Montarroyos, I Coimbra, D de B Miranda-Filho, M de F Albuquerque, HR Lacerda, RAA Ximenes

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Tuberculosis is a serious public health problem worldwide. It is the leading cause of death amongst people living with HIV, and default from tuberculosis (TB) treatment in people living with HIV increases the probability of death. The aim of this study was to estimate the survival probability of people living with HIV who default treatment for TB compared to those who complete the treatment.

Methods

This was a longitudinal cohort study of people living with HIV, from June 2007 to December 2013 with two components: a retrospective (for those who started tuberculosis treatment before 2013 for whom failure (death) or censoring occurred before 2013), and prospective (those who started tuberculosis treatment at any time between 2007 and June 2013 and for whom death or censoring occurred after the beginning of 2013), at two referral hospitals for people living with HIV (Correia Picanço Hospital - HCP and at Hospital Universitário Oswaldo Cruz – HUOC), in Recife/PE. A total of 317 patients who initiated TB treatment were studied. Default from TB treatment was defined as any patient who failed to attend their pre-booked return appointment at the health center for more than 30 consecutive days, in accordance with Brazilian Ministry of Health recommendations.

Results

From a cohort of 2372 people living with HIV we analyzed 317 patients who had initiated TB treatment. The incidence of death was 5.6 deaths per 100 persons per year (CI 95% 4.5 to 7.08). Independent factors associated with death: default from TB treatment 3.65 HR (95% CI 2.28 to 5.83); CD4 < 200 cells/mm3 2.39 HR (95% CI 1.44 to 3.96); extrapulmonary tuberculosis 1.56 HR (95% CI 0.93 to 2.63); smoking 2.28 HR (95% CI 1.33 to 3.89); alcohol light 0.13 HR (95% CI 0.03 to 0.56).

Conclusion

The probability of death in people living with HIV who default TB treatment is approximately four times greater when compared to those who do not default from treatment.
Literature
1.
go back to reference World Health Organization. Global tuberculosis report 2014. Geneva: WHO; 2014. World Health Organization. Global tuberculosis report 2014. Geneva: WHO; 2014.
2.
go back to reference World Health Organization. WHO news release. Saudi Med J. 2013;34(11):1205–7. World Health Organization. WHO news release. Saudi Med J. 2013;34(11):1205–7.
3.
go back to reference World Health Organization. Global tuberculosis report 2013. Geneva: WHO; 2013. World Health Organization. Global tuberculosis report 2013. Geneva: WHO; 2013.
4.
go back to reference Schmaltz CAS, Santoro-Lopes G, Lourenço MC, Morgado MG, Velasque LDS, Rolla VC. Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART. PLoS One. 2012;7(9):e45704.CrossRefPubMedPubMedCentral Schmaltz CAS, Santoro-Lopes G, Lourenço MC, Morgado MG, Velasque LDS, Rolla VC. Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART. PLoS One. 2012;7(9):e45704.CrossRefPubMedPubMedCentral
5.
go back to reference Naidoo P, Peltzer K, Louw J, Matseke G, Mchunu G, Tushana B. Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study. BMC Public Health. 2013;13:396.CrossRefPubMedPubMedCentral Naidoo P, Peltzer K, Louw J, Matseke G, Mchunu G, Tushana B. Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study. BMC Public Health. 2013;13:396.CrossRefPubMedPubMedCentral
6.
go back to reference Yuen CM, Weyenga HO, Kim AA, Malika T, Muttai H, Katana A, et al. Comparison of trends in tuberculosis incidence among adults living with HIV and adults without HIV - Kenya, 1998–2012. PLoS One. 2014;9(6):e99880.CrossRefPubMedPubMedCentral Yuen CM, Weyenga HO, Kim AA, Malika T, Muttai H, Katana A, et al. Comparison of trends in tuberculosis incidence among adults living with HIV and adults without HIV - Kenya, 1998–2012. PLoS One. 2014;9(6):e99880.CrossRefPubMedPubMedCentral
7.
go back to reference Domingos M, Caiaffa W, Colosimo E. Mortality, TB/HIV co-infection, and treatment dropout: predictors of tuberculosis prognosis in Recife, Pernambuco State, Brazil. Cad Saúde Pública. 2008;24(4):887–96.CrossRefPubMed Domingos M, Caiaffa W, Colosimo E. Mortality, TB/HIV co-infection, and treatment dropout: predictors of tuberculosis prognosis in Recife, Pernambuco State, Brazil. Cad Saúde Pública. 2008;24(4):887–96.CrossRefPubMed
8.
go back to reference Geldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, Heeregrave EJ, et al. Preferential infection and depletion of Mycobacterium tuberculosisspecific CD4 T cells after HIV-1 infection. J Exp Med. 2010;207(13):2869–81.CrossRefPubMedPubMedCentral Geldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, Heeregrave EJ, et al. Preferential infection and depletion of Mycobacterium tuberculosisspecific CD4 T cells after HIV-1 infection. J Exp Med. 2010;207(13):2869–81.CrossRefPubMedPubMedCentral
9.
go back to reference Ministério da Saúde Brasil.Secretária -Executiva.Subsecretaria de Assuntos Administrativos Coordenaçào Geral de Documentação e Informação, Editorial C de G, organizadores. Ministério da Saúde. Secretária Executiva. Recomendações para o Manejo da co-infecção TB-HIV em Serviços de Atenção Especializada a pessoas vivendo com HIV/Aids. Ministério da Saúde. Secretaria-Executiva – Brasília. MS. 2013. Ministério da Saúde Brasil.Secretária -Executiva.Subsecretaria de Assuntos Administrativos Coordenaçào Geral de Documentação e Informação, Editorial C de G, organizadores. Ministério da Saúde. Secretária Executiva. Recomendações para o Manejo da co-infecção TB-HIV em Serviços de Atenção Especializada a pessoas vivendo com HIV/Aids. Ministério da Saúde. Secretaria-Executiva – Brasília. MS. 2013.
10.
go back to reference Lawn SD. AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. J Infect. 2004;48:1–12.CrossRefPubMed Lawn SD. AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. J Infect. 2004;48:1–12.CrossRefPubMed
11.
go back to reference Ministério da Saúde. Secretaria de Vigilância em Saúde. Boletim Epidemiológico Especial Tuberculose. Brasil - MS, 2012. v.43. Ministério da Saúde. Secretaria de Vigilância em Saúde. Boletim Epidemiológico Especial Tuberculose. Brasil - MS, 2012. v.43.
12.
go back to reference Joint United Nations Programme on HIV/AIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. Global Report 2013. Joint United Nations Programme on HIV/AIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. Global Report 2013.
13.
go back to reference Grinsztejn B, Veloso V, Friedman R, Moreira R, Luz P, Campos D, et al. Early mortality and cause of deaths in patients using HAART in Brazil and the United States. AIDS. 2013;23(16):2107–14.CrossRef Grinsztejn B, Veloso V, Friedman R, Moreira R, Luz P, Campos D, et al. Early mortality and cause of deaths in patients using HAART in Brazil and the United States. AIDS. 2013;23(16):2107–14.CrossRef
14.
go back to reference Rodrigues AM, Scatena M, Helena S, Vendramini F, Marin SR, Canini S, et al. Avaliação do acesso ao tratamento de tuberculose por coinfectados ou não pelo vírus da imunodeficiência humana. Rev Esc Enferm USP. 2012;46(5):1163–9.CrossRefPubMed Rodrigues AM, Scatena M, Helena S, Vendramini F, Marin SR, Canini S, et al. Avaliação do acesso ao tratamento de tuberculose por coinfectados ou não pelo vírus da imunodeficiência humana. Rev Esc Enferm USP. 2012;46(5):1163–9.CrossRefPubMed
15.
go back to reference Maruza M, Albuquerque MFPM, Coimbra I, Moura LV, Montarroyos UR, Miranda Filho DB, et al. Risk factors for default from tuberculosis treatment in HIV-infected individuals in the state of Pernambuco, Brazil: a prospective cohort study. BMC Infect Dis. 2011;11:351.CrossRefPubMedPubMedCentral Maruza M, Albuquerque MFPM, Coimbra I, Moura LV, Montarroyos UR, Miranda Filho DB, et al. Risk factors for default from tuberculosis treatment in HIV-infected individuals in the state of Pernambuco, Brazil: a prospective cohort study. BMC Infect Dis. 2011;11:351.CrossRefPubMedPubMedCentral
16.
go back to reference Muture B, Keraka M, Kimuu P, Karibu E, Ombeka V, Oguya F. Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study. BMC Public Health. 2011;11(696):1–10. Muture B, Keraka M, Kimuu P, Karibu E, Ombeka V, Oguya F. Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study. BMC Public Health. 2011;11(696):1–10.
17.
go back to reference Zhang Q, Gaafer M, El Bayoumy I. Determinants of default from pulmonary tuberculosis treatment in Kuwait. Sci World J. 2014;14:672825. Zhang Q, Gaafer M, El Bayoumy I. Determinants of default from pulmonary tuberculosis treatment in Kuwait. Sci World J. 2014;14:672825.
18.
go back to reference Albuquerque M, Ximenes R, Silva N, Souza W, Dantas A, Dantas O, et al. Factors associated with treatment failure, dropout, and death in a cohort of tuberculosis patients in Recife, Pernambuco State, Brazil. Cad Saúde Pública. 2007;23(7):1573–82.CrossRef Albuquerque M, Ximenes R, Silva N, Souza W, Dantas A, Dantas O, et al. Factors associated with treatment failure, dropout, and death in a cohort of tuberculosis patients in Recife, Pernambuco State, Brazil. Cad Saúde Pública. 2007;23(7):1573–82.CrossRef
19.
go back to reference Vree M, Huong NT, Duong BD, Sy DN, Van LN, Co NV, et al. Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study. BMC Public Health. 2007;7:134.CrossRefPubMedPubMedCentral Vree M, Huong NT, Duong BD, Sy DN, Van LN, Co NV, et al. Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study. BMC Public Health. 2007;7:134.CrossRefPubMedPubMedCentral
20.
go back to reference Medina, Claudia & Rochel, Kenneth. RecLink III – Relacionamento Probabilístico de Registros. Versão 3.1.6.3160. 2007. Medina, Claudia & Rochel, Kenneth. RecLink III – Relacionamento Probabilístico de Registros. Versão 3.1.6.3160. 2007.
21.
go back to reference Alobu I, Oshi SN, Oshi DC, Ukwaja KN. Risk factors of treatment default and death among tuberculosis patients in a resource-limited setting. Asian Pac J Trop Med. 2014;7:977–84.CrossRefPubMed Alobu I, Oshi SN, Oshi DC, Ukwaja KN. Risk factors of treatment default and death among tuberculosis patients in a resource-limited setting. Asian Pac J Trop Med. 2014;7:977–84.CrossRefPubMed
22.
go back to reference Kaona FAD, Tuba M, Siziya S, Sikaona L. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004;4:68.CrossRefPubMedPubMedCentral Kaona FAD, Tuba M, Siziya S, Sikaona L. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004;4:68.CrossRefPubMedPubMedCentral
23.
go back to reference Lawn SD, Butera ST, Folks TM. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev. 2001;14(4):753–77.CrossRefPubMedPubMedCentral Lawn SD, Butera ST, Folks TM. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev. 2001;14(4):753–77.CrossRefPubMedPubMedCentral
24.
go back to reference Karo B, Haas W, Kollan C, Gunsenheimer-Bartmeyer B, Hamouda O, Fiebig L. Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors. BMC Infect Dis. 2014;14(1):1–12.CrossRef Karo B, Haas W, Kollan C, Gunsenheimer-Bartmeyer B, Hamouda O, Fiebig L. Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors. BMC Infect Dis. 2014;14(1):1–12.CrossRef
25.
go back to reference Lawn SD, Myer L, Bekker L-G, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006;20:1605–12.CrossRefPubMed Lawn SD, Myer L, Bekker L-G, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006;20:1605–12.CrossRefPubMed
26.
go back to reference Hoffman J, Van Griensven J, Colebunders R, McKellar M. Role of the CD4 count in HIV management. HIV Ther. 2010;4(1):27–39.CrossRef Hoffman J, Van Griensven J, Colebunders R, McKellar M. Role of the CD4 count in HIV management. HIV Ther. 2010;4(1):27–39.CrossRef
27.
go back to reference Langford SE, Ananworanich J, Cooper DA. Predictors of disease progression in HIV infection: a review. AIDS Res Ther. 2007;4(11):1–14. Langford SE, Ananworanich J, Cooper DA. Predictors of disease progression in HIV infection: a review. AIDS Res Ther. 2007;4(11):1–14.
28.
go back to reference Oshi DC, Oshi SN, Alobu I, Ukwaja KN. Profile, outcomes, and determinants of unsuccessful tuberculosis treatment outcomes among HIV-infected tuberculosis patients in a Nigerian State. 2015. p. 2014. Oshi DC, Oshi SN, Alobu I, Ukwaja KN. Profile, outcomes, and determinants of unsuccessful tuberculosis treatment outcomes among HIV-infected tuberculosis patients in a Nigerian State. 2015. p. 2014.
29.
go back to reference Kingkaew N, Sangtong B, Amnuaiphon W, Jongpaibulpatana J, Mankatittham W, Akksilp S, et al. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death. Int J Infect Dis. 2009;13(6):722–9.CrossRefPubMed Kingkaew N, Sangtong B, Amnuaiphon W, Jongpaibulpatana J, Mankatittham W, Akksilp S, et al. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death. Int J Infect Dis. 2009;13(6):722–9.CrossRefPubMed
30.
31.
go back to reference Jee S, Golub J, Jo J, Park I, Ohrr H, Samet J. Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol. 2009;170(12):1478–85.CrossRefPubMedPubMedCentral Jee S, Golub J, Jo J, Park I, Ohrr H, Samet J. Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol. 2009;170(12):1478–85.CrossRefPubMedPubMedCentral
32.
go back to reference Volkmann T, Moonan PK, Miramontes R, Oeltmann JE. Tuberculosis and excess alcohol use in the United States. Int J Tuberc Lung Dis. 2015;19(1):111–119.CrossRefPubMedPubMedCentral Volkmann T, Moonan PK, Miramontes R, Oeltmann JE. Tuberculosis and excess alcohol use in the United States. Int J Tuberc Lung Dis. 2015;19(1):111–119.CrossRefPubMedPubMedCentral
33.
go back to reference Maruza M, Albuquerque MFPM, Braga MC, Barbosa MTS, Byington R, Coimbra I, et al. Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study. Int J Tuberc Lung Dis. 2012;16:618–24.PubMed Maruza M, Albuquerque MFPM, Braga MC, Barbosa MTS, Byington R, Coimbra I, et al. Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study. Int J Tuberc Lung Dis. 2012;16:618–24.PubMed
Metadata
Title
Survival of people living with HIV who defaulted from tuberculosis treatment in a cohort, Recife, Brazil
Authors
R Cunha
M Maruza
UR Montarroyos
I Coimbra
D de B Miranda-Filho
M de F Albuquerque
HR Lacerda
RAA Ximenes
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-2127-5

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue